Here's What to Expect From Amgen’s Next Earnings Report

With a market cap of $158.6 billion, Amgen Inc. (AMGN) is a leading global biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics for serious illnesses, with a strong emphasis on oncology, nephrology, cardiovascular disease, and inflammation. The company is expected to release its fiscal Q3 2025 earnings results after the market closes on Tuesday, Nov. 4. Ahead of this event, a ...